TEVA DENMARK A/S: Financial statements 2012
CVR: 29634076
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
TEVA DENMARK A/S (CVR 29634076) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 26,315,460 and a net result of DKK 1,638,293. Equity in the 2012 report amounted to DKK 34,980,198. The solvency ratio was 24.8%.
- Gross Profit
- DKK 26,315,460
- Profit/Loss
- DKK 1,638,293
- Equity
- DKK 34,980,198
- Total Assets
- DKK 141,127,669
Official annual report
Keep an eye on TEVA DENMARK A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of September 12, 2012, is registered as an owner of TEVA DENMARK A/S with an ownership share of 100%.
As of June 4, 2012, Kim Vallentin Peetz has joined the board of directors of TEVA DENMARK A/S.
As of June 4, 2012, Peter Mikael Burestedt has joined the board of directors of TEVA DENMARK A/S.
As of June 4, 2012, Lone Juul Darket has left the board of directors of TEVA DENMARK A/S.
As of June 4, 2012, Emile Gérardus Wilhelmus Hendr icus Loof has left the board of directors of TEVA DENMARK A/S.
As of June 4, 2012, Peter Mikael Burestedt is registered as adm. dir. of TEVA DENMARK A/S.
As of June 4, 2012, Lone Juul Darket has stepped down as director of TEVA DENMARK A/S.
About TEVA DENMARK A/S
TEVA DENMARK A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Morten Nielsen and Bjarne Palle Niemi. The board consists of Helle Grinderslev Kramp, Mirko Vonk and Morten Nielsen. The company is owned by Teva Pharma B.V.. The company has 39 employees (2018). In 2025, the company reported revenue of DKK 645,331,000 and a net result of DKK 46,817,000 compared with DKK 57,422,000 the year before. Equity in the 2025 report amounted to DKK 113,670,000.
